81_FR_62923 81 FR 62747 - National Cancer Institute; Amended Notice of Meeting

81 FR 62747 - National Cancer Institute; Amended Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 81, Issue 176 (September 12, 2016)

Page Range62747-62747
FR Document2016-21786

Federal Register, Volume 81 Issue 176 (Monday, September 12, 2016)
[Federal Register Volume 81, Number 176 (Monday, September 12, 2016)]
[Notices]
[Page 62747]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-21786]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Special Emphasis Panel, October 26, 2016, 11:00 a.m. 
to October 26, 2016, 5:00 p.m., National Cancer Institute Shady Grove, 
9609 Medical Center Drive, 4W034, Rockville, MD 20850 which was 
published in the Federal Register on August 25, 2016, 81 FR 58524.
    The meeting notice is amended to change the date of the meeting to 
November 15, 2016 from 11:00 a.m. to 5:00 p.m. The meeting is closed to 
the public.

    Dated: September 6, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-21786 Filed 9-9-16; 8:45 am]
 BILLING CODE 4140-01-P



                                                                          Federal Register / Vol. 81, No. 176 / Monday, September 12, 2016 / Notices                                              62747

                                                260 submissions of 510(k)s for third                    DEPARTMENT OF HEALTH AND                              Institute, 9609 Medical Center Drive, Room
                                                party review per year.                                  HUMAN SERVICES                                        7W556, Rockville, MD 20892–9750, 240–
                                                                                                                                                              276–6411 sahab@mail.nih.gov.
                                                  Proposed revisions to the currently                                                                           Name of Committee: National Cancer
                                                approved information collection:                        National Institutes of Health
                                                                                                                                                              Institute Special Emphasis Panel Cancer
                                                • Reporting                                             National Cancer Institute; Amended                    Tissue Engineering Collaborative: Enabling
                                                                                                        Notice of Meeting                                     Biomimetic Tissue-Engineered Technologies
                                                  Æ Requests for rerecognition: The                                                                           for Cancer Research (U01).
                                                Agency anticipates an average annual                      Notice is hereby given of a change in                 Date: October 14, 2016.
                                                receipt of four applications for                        the meeting of the National Cancer                      Time: 8:00 a.m. to 6:00 p.m.
                                                rerecognition for third party 510(k)                    Institute Special Emphasis Panel,                       Agenda: To review and evaluate grant
                                                                                                        October 26, 2016, 11:00 a.m. to October               applications.
                                                review. The Agency reached this                                                                                 Place: Bethesda North Marriott Hotel &
                                                estimate by reviewing the number of                     26, 2016, 5:00 p.m., National Cancer
                                                                                                                                                              Conference Center, 5701 Marinelli Road,
                                                existing recognized firms under the TP                  Institute Shady Grove, 9609 Medical                   Bethesda, MD 20852.
                                                Review Program and anticipating the                     Center Drive, 4W034, Rockville, MD                      Contact Person: Nadeem Khan, Ph.D.,
                                                number of firms applying for                            20850 which was published in the                      Scientific Review Officer, Research
                                                rerecognition every 3 years.                            Federal Register on August 25, 2016, 81               Technology and Contract Review Branch,
                                                                                                        FR 58524.                                             Division of Extramural Activities, National
                                                • Recordkeeping                                           The meeting notice is amended to                    Cancer Institute, 9609 Medical Center Drive,
                                                                                                        change the date of the meeting to                     Room 7W260, Rockville, MD 20892–9750
                                                   Æ The Agency expects TP Review
                                                                                                        November 15, 2016 from 11:00 a.m. to                  240–276–5856, nadeem.khan@nih.gov.
                                                Organizations to retain and maintain
                                                                                                        5:00 p.m. The meeting is closed to the                  Name of Committee: National Cancer
                                                documentation related to recognition
                                                                                                        public.                                               Institute Special Emphasis Panel Cooperative
                                                and rerecognition.                                                                                            Agreement to Develop Targeted Agents for
                                                   The respondents for this information                   Dated: September 6, 2016.                           use with Systemic Agents Plus Radiotherapy
                                                collection are private sector, for-profit               Melanie J. Gray,                                      (U01).
                                                firms seeking recognition and                           Program Analyst, Office of Federal Advisory             Date: October 21, 2016.
                                                rerecognition.                                          Committee Policy.                                       Time: 10:00 a.m. to 5:00 p.m.
                                                                                                        [FR Doc. 2016–21786 Filed 9–9–16; 8:45 am]              Agenda: To review and evaluate grant
                                                   The draft guidance also refers to                                                                          applications.
                                                                                                        BILLING CODE 4140–01–P
                                                previously approved collections of                                                                              Place: National Cancer Institute Shady
                                                information found in FDA regulations.                                                                         Grove, 9609 Medical Center Drive, Room
                                                The collections of information in 21                                                                          7W030, Rockville, MD 20850 (Telephone
                                                                                                        DEPARTMENT OF HEALTH AND                              Conference Call).
                                                CFR part 807, subpart E have been                       HUMAN SERVICES
                                                approved under OMB control number                                                                               Contact Person: Thomas A. Winters, Ph.D.,
                                                                                                                                                              Scientific Review Officer, Special Review
                                                0910–0120; collections of information                   National Institutes of Health                         Branch, Division of Extramural Activities,
                                                for the device appeals processes have                                                                         National Cancer Institute, 9609 Medical
                                                been approved under OMB control                         National Cancer Institute; Notice of                  Center Drive, Room 7W412, Rockville, MD
                                                number 0910–0738.                                       Closed Meetings                                       20892–9750, 240–276–6386, twinters@
                                                                                                                                                              mail.nih.gov.
                                                V. References                                             Pursuant to section 10(d) of the
                                                                                                        Federal Advisory Committee Act, as                      Name of Committee: National Cancer
                                                  The following references have been                                                                          Institute Initial Review Group Subcommittee
                                                                                                        amended (5 U.S.C. App.), notice is
                                                placed on display in the Division of                                                                          F—Institutional Training and Education.
                                                                                                        hereby given of the following meetings.                 Date: October 24–25, 2016.
                                                Dockets Management (see ADDRESSES),                       The meetings will be closed to the                    Time: 7:30 p.m. to 3:45 p.m.
                                                and are available for viewing by                        public in accordance with the                           Agenda: To review and evaluate grant
                                                interested persons between 9 a.m. and 4                 provisions set forth in sections                      applications.
                                                p.m., Monday through Friday; they are                   552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              Place: Bethesda Marriott, 5151 Pooks Hill
                                                also available electronically at http://                as amended. The grant applications and                Road, Bethesda, MD 20814.
                                                www.regulations.gov. FDA has verified                   the discussions could disclose                          Contact Person: Timothy C. Meeker, Ph.D.,
                                                the Web site addresses, as of the date                  confidential trade secrets or commercial              Scientific Review Officer, Resources and
                                                this document publishes in the Federal                  property such as patentable material,                 Training Review Branch, Division of
                                                Register but Web sites are subject to                                                                         Extramural Activities, National Cancer
                                                                                                        and personal information concerning                   Institute, 9609 Medical Center Drive, Room
                                                change over time.                                       individuals associated with the grant                 7W606, Rockville, MD 20892–9750, 240–
                                                   1. International Medical Device Regulators           applications, the disclosure of which                 276–6464, meekert@mail.nih.gov.
                                                Forum’s Medical Device Single Audit                     would constitute a clearly unwarranted                  Name of Committee: National Cancer
                                                Program documents, available at http://                 invasion of personal privacy.                         Institute Special Emphasis Panel, NCI
                                                imdrf.org/documents/documents.asp.                                                                            Clinical and Translational, R21: SEP–7.
                                                                                                          Name of Committee: National Cancer
                                                   2. FDA Draft Guidance entitled                                                                               Date: October 27, 2016.
                                                                                                        Institute Special Emphasis Panel R13
                                                ‘‘Accreditation and Reaccreditation Process                                                                     Time: 10:00 a.m. to 1:00 p.m.
                                                                                                        Conference Grant Review.
                                                for Firms under the Third Party Review                                                                          Agenda: To review and evaluate grant
                                                                                                          Date: October 11, 2016.
                                                Program: Part I,’’ February 15, 2013, available           Time: 12:00 p.m. to 6:00 p.m.                       applications.
                                                at http://www.fda.gov/downloads/                          Agenda: To review and evaluate grant                  Place: National Cancer Institute Shady
                                                MedicalDevices/                                         applications.                                         Grove, 9609 Medical Center Drive, Rockville,
sradovich on DSK3GMQ082PROD with NOTICES




                                                DeviceRegulationandGuidance/                              Place: National Cancer Institute Shady              MD 20850 (Telephone Conference Call).
                                                GuidanceDocuments/UCM339697.pdf.                        Grove, 9609 Medical Center Drive, Room                  Contact Person: Caron A. Lyman, Ph.D.,
                                                  Dated: September 6, 2016.                             7W556, Rockville, MD 20850 (Telephone                 Chief, Scientific Review Officer, Research
                                                Leslie Kux,                                             Conference Call).                                     Programs Review Branch, Division of
                                                                                                          Contact Person: Bratin K. Saha, Ph.D.,              Extramural Activities, National Cancer
                                                Associate Commissioner for Policy.                                                                            Institute, 9609 Medical Center Drive, Room
                                                                                                        Scientific Review Officer, Program
                                                [FR Doc. 2016–21876 Filed 9–9–16; 8:45 am]              Coordination and Referral Branch, Division            7W126, Rockville, MD 20892–9750, 240–
                                                BILLING CODE 4164–01–P                                  of Extramural Activities, National Cancer             276–6348, lymanc@mail.nih.gov.



                                           VerDate Sep<11>2014   18:40 Sep 09, 2016   Jkt 238001   PO 00000   Frm 00047   Fmt 4703   Sfmt 4703   E:\FR\FM\12SEN1.SGM   12SEN1



Document Created: 2016-09-10 00:56:44
Document Modified: 2016-09-10 00:56:44
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation81 FR 62747 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR